Land: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Piperacillin; Tazobactam
Noridem Enterprises Limited
J01CR; J01CR05
Piperacillin; Tazobactam
4 g / 0.5 gram(s)
Powder for solution for infusion
Product subject to prescription which may not be renewed (A)
Combinations of penicillins, incl. beta-lactamase inhibitors; piperacillin and enzyme inhibitor
Not marketed
2011-11-18
PACKAGE LEAFLET: INFORMATION FOR THE USER PIPERACILLIN/TAZOBACTAM 2G/0.25G POWDER FOR SOLUTION FOR INFUSION PIPERACILLIN/TAZOBACTAM 4G/0.5G POWDER FOR SOLUTION FOR INFUSION piperacillin / tazobactam READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. THE NAME OF YOUR MEDICINE IS ONE OF THE FOLLOWING: - Piperacillin/Tazobactam 2g/0.25g Powder for solution for infusion - Piperacillin/Tazobactam 4g/0.5g Powder for solution for infusion _In the rest of this leaflet your medicine is called Piperacillin/Tazobactam. _ WHAT IS IN THIS LEAFLET 1. What Piperacillin/Tazobactam is and what it is used for 2. What you need to know before you are given Piperacillin/Tazobactam 3. How Piperacillin/Tazobactam is given 4. Possible side effects 5. How to store Piperacillin/Tazobactam 6. Contents of the pack and other information 1. WHAT PIPERACILLIN/TAZOBACTAM IS AND WHAT IT IS USED FOR Piperacillin belongs to the group of medicines known as “broad-spectrum penicillin antibiotics”. It can kill many kinds of bacteria. Tazobactam can prevent some resistant bacteria from surviving the effects of piperacillin. This means that when piperacillin and tazobactam are given together, more types of bacteria are killed. Piperacillin/Tazobactam is used in adults and adolescents to treat bacterial infections, such as those affecting the lower respiratory tract (lungs), urinary tract (kidneys and bladder), abdomen, skin or blood. Piperacillin/Tazobactam may be used to treat bacterial infections in patients with low white blood cell counts (reduced Lestu allt skjalið
Health Products Regulatory Authority 11 March 2022 CRN00CSZZ Page 1 of 14 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Piperacillin/Tazobactam 4g/0.5g powder for solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 30mL vial contains 4.17g of piperacillin sodium, equivalent to 4g of piperacillin and 0.536g tazobactam sodium equivalent to 0.5g of tazobactam. Excipient with known effect Sodium content: 9.4mmol (216.2mg) of sodium/vial of Powder for solution for infusion. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder for solution for infusion. White to light yellow crystalline powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Piperacillin/Tazobactam is indicated for the treatment of the following infections in adults and children over 2 years of age (see sections 4.2 and 5.1): ADULTS AND ADOLESCENTS ● Severe pneumonia including hospital-acquired and ventilator-associated pneumonia ● Complicated urinary tract infections (including pyelonephritis) ● Complicated intra-abdominal infections ● Complicated skin and soft tissue infections (including diabetic foot infections) Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Piperacillin/Tazobactam may be used in the management of neutropenic patients with fever suspected to be due to a bacterial infection. CHILDREN 2 TO 12 YEARS OF AGE ● Complicated intra-abdominal infections Piperacillin/Tazobactam may be used in the management of neutropenic children with fever suspected to be due to a bacterial infection. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Health Products Regulatory Authority 11 March 2022 CRN00CSZZ Page 2 of 14 The dose and frequency of Piperacillin/Tazobactam depends on the severity and localisation of the infection and expected pathogens. _Adult and adolescent patients _ Lestu allt skjalið